
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Curcumin and tumor immune-editing: resurrecting the immune system
Sayantan Bose, Abir K. Panda, Shravanti Mukherjee, et al.
Cell Division (2015) Vol. 10, Iss. 1
Open Access | Times Cited: 145
Sayantan Bose, Abir K. Panda, Shravanti Mukherjee, et al.
Cell Division (2015) Vol. 10, Iss. 1
Open Access | Times Cited: 145
Showing 1-25 of 145 citing articles:
Carotenoids: biochemistry, pharmacology and treatment
Alireza Milani, Marzieh Basirnejad, Sepideh Shahbazi, et al.
British Journal of Pharmacology (2016) Vol. 174, Iss. 11, pp. 1290-1324
Open Access | Times Cited: 662
Alireza Milani, Marzieh Basirnejad, Sepideh Shahbazi, et al.
British Journal of Pharmacology (2016) Vol. 174, Iss. 11, pp. 1290-1324
Open Access | Times Cited: 662
Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives
Xiaoyu Xu, Xiao Meng, Sha Li, et al.
Nutrients (2018) Vol. 10, Iss. 10, pp. 1553-1553
Open Access | Times Cited: 292
Xiaoyu Xu, Xiao Meng, Sha Li, et al.
Nutrients (2018) Vol. 10, Iss. 10, pp. 1553-1553
Open Access | Times Cited: 292
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Qinghua Wu, You Li, Eugenie Nepovimová, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 261
Qinghua Wu, You Li, Eugenie Nepovimová, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 261
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients
Hamed Valizadeh, Samaneh Abdolmohammadi‐Vahid, Svetlana Danshina, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107088-107088
Open Access | Times Cited: 242
Hamed Valizadeh, Samaneh Abdolmohammadi‐Vahid, Svetlana Danshina, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107088-107088
Open Access | Times Cited: 242
Curcumin Nanoformulations for Colorectal Cancer: A Review
Kar En Wong, Siew Ching Ngai, Kok‐Gan Chan, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 226
Kar En Wong, Siew Ching Ngai, Kok‐Gan Chan, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 226
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies
Alessandro Allegra, Vanessa Innao, Sabina Russo, et al.
Cancer Investigation (2016) Vol. 35, Iss. 1, pp. 1-22
Closed Access | Times Cited: 211
Alessandro Allegra, Vanessa Innao, Sabina Russo, et al.
Cancer Investigation (2016) Vol. 35, Iss. 1, pp. 1-22
Closed Access | Times Cited: 211
New insights into therapeutic activity and anticancer properties of curcumin
Abir K. Panda, Dwaipayan Chakraborty, Irene Sarkar, et al.
Journal of Experimental Pharmacology (2017) Vol. Volume 9, pp. 31-45
Open Access | Times Cited: 188
Abir K. Panda, Dwaipayan Chakraborty, Irene Sarkar, et al.
Journal of Experimental Pharmacology (2017) Vol. Volume 9, pp. 31-45
Open Access | Times Cited: 188
Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy
Shaloam Dasari, Sylvianne Njiki, Ariane Mbemi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1532-1532
Open Access | Times Cited: 177
Shaloam Dasari, Sylvianne Njiki, Ariane Mbemi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1532-1532
Open Access | Times Cited: 177
Experimental and clinical reports on anti‐inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review
Arghavan Memarzia, Mohammad Reza Khazdair, Sepideh Behrouz, et al.
BioFactors (2021) Vol. 47, Iss. 3, pp. 311-350
Closed Access | Times Cited: 139
Arghavan Memarzia, Mohammad Reza Khazdair, Sepideh Behrouz, et al.
BioFactors (2021) Vol. 47, Iss. 3, pp. 311-350
Closed Access | Times Cited: 139
Polysaccharide-based nanomedicines for cancer immunotherapy: A review
Yujun Zeng, Yufan Xiang, Ruilong Sheng, et al.
Bioactive Materials (2021) Vol. 6, Iss. 10, pp. 3358-3382
Open Access | Times Cited: 121
Yujun Zeng, Yufan Xiang, Ruilong Sheng, et al.
Bioactive Materials (2021) Vol. 6, Iss. 10, pp. 3358-3382
Open Access | Times Cited: 121
Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy
Rana Shafabakhsh, Mohammad Hossein Pourhanifeh, Hamid Reza Mirzaei, et al.
Pharmacological Research (2019) Vol. 147, pp. 104353-104353
Closed Access | Times Cited: 138
Rana Shafabakhsh, Mohammad Hossein Pourhanifeh, Hamid Reza Mirzaei, et al.
Pharmacological Research (2019) Vol. 147, pp. 104353-104353
Closed Access | Times Cited: 138
Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization
Anita Thyagarajan, Ravi P. Sahu
Integrative Cancer Therapies (2017) Vol. 17, Iss. 2, pp. 210-216
Open Access | Times Cited: 122
Anita Thyagarajan, Ravi P. Sahu
Integrative Cancer Therapies (2017) Vol. 17, Iss. 2, pp. 210-216
Open Access | Times Cited: 122
Immunomodulatory, anti-inflammatory, and antioxidant effects of curcumin
Nadia Boroumand, Saeed Samarghandian, Seyed Isaac Hashemy
Journal of Herbmed Pharmacology (2018) Vol. 7, Iss. 4, pp. 211-219
Open Access | Times Cited: 122
Nadia Boroumand, Saeed Samarghandian, Seyed Isaac Hashemy
Journal of Herbmed Pharmacology (2018) Vol. 7, Iss. 4, pp. 211-219
Open Access | Times Cited: 122
<p>Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor</p>
Xianguang Bai, Ming Yi, Ying Jiao, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 9527-9538
Open Access | Times Cited: 112
Xianguang Bai, Ming Yi, Ying Jiao, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 9527-9538
Open Access | Times Cited: 112
Engineered nanoparticles for imaging and drug delivery in colorectal cancer
E. Pavitra, Begum Dariya, Gowru Srivani, et al.
Seminars in Cancer Biology (2019) Vol. 69, pp. 293-306
Closed Access | Times Cited: 104
E. Pavitra, Begum Dariya, Gowru Srivani, et al.
Seminars in Cancer Biology (2019) Vol. 69, pp. 293-306
Closed Access | Times Cited: 104
Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy
Yu‐Ting Cheng, Chun-Chih Yang, Lie‐Fen Shyur
Pharmacological Research (2016) Vol. 114, pp. 128-143
Closed Access | Times Cited: 87
Yu‐Ting Cheng, Chun-Chih Yang, Lie‐Fen Shyur
Pharmacological Research (2016) Vol. 114, pp. 128-143
Closed Access | Times Cited: 87
Curcumin as tyrosine kinase inhibitor in cancer treatment
Aleksandra Golonko, Hanna Lewandowska, Renata Świsłocka, et al.
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111512-111512
Open Access | Times Cited: 80
Aleksandra Golonko, Hanna Lewandowska, Renata Świsłocka, et al.
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111512-111512
Open Access | Times Cited: 80
Nanotechnology in Colorectal Cancer for Precision Diagnosis and Therapy
Basanti Brar, Koushlesh Ranjan, Ankur Palria, et al.
Frontiers in Nanotechnology (2021) Vol. 3
Open Access | Times Cited: 64
Basanti Brar, Koushlesh Ranjan, Ankur Palria, et al.
Frontiers in Nanotechnology (2021) Vol. 3
Open Access | Times Cited: 64
Curcumin delivery and co-delivery based on nanomaterials as an effective approach for cancer therapy
Mehrab Pourmadadi, Parisa Abbasi, Mohammad Mahdi Eshaghi, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 78, pp. 103982-103982
Closed Access | Times Cited: 45
Mehrab Pourmadadi, Parisa Abbasi, Mohammad Mahdi Eshaghi, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 78, pp. 103982-103982
Closed Access | Times Cited: 45
Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances
Phanindra Babu Kasi, Venkata Ramana Mallela, Filip Ambrożkiewicz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7922-7922
Open Access | Times Cited: 25
Phanindra Babu Kasi, Venkata Ramana Mallela, Filip Ambrożkiewicz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7922-7922
Open Access | Times Cited: 25
Tumor microenvironment remodeling in oral cancer: Application of plant derived-natural products and nanomaterials
Hendrik Setia Budi, Bagher Farhood
Environmental Research (2023) Vol. 233, pp. 116432-116432
Closed Access | Times Cited: 25
Hendrik Setia Budi, Bagher Farhood
Environmental Research (2023) Vol. 233, pp. 116432-116432
Closed Access | Times Cited: 25
Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer
Junyi Zhang, Kamran Ali, Jianwei Wang
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6693-6715
Open Access | Times Cited: 9
Junyi Zhang, Kamran Ali, Jianwei Wang
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6693-6715
Open Access | Times Cited: 9
The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
Yahua Wang, Xue Ying, Haolun Xu, et al.
International Journal of Nanomedicine (2017) Vol. Volume 12, pp. 1369-1384
Open Access | Times Cited: 79
Yahua Wang, Xue Ying, Haolun Xu, et al.
International Journal of Nanomedicine (2017) Vol. Volume 12, pp. 1369-1384
Open Access | Times Cited: 79
Curcumin blocks autophagy and activates apoptosis of malignant mesothelioma cell lines and increases the survival of mice intraperitoneally transplanted with a malignant mesothelioma cell line
Laura Masuelli, Monica Benvenuto, Enrica Di Stefano, et al.
Oncotarget (2017) Vol. 8, Iss. 21, pp. 34405-34422
Open Access | Times Cited: 74
Laura Masuelli, Monica Benvenuto, Enrica Di Stefano, et al.
Oncotarget (2017) Vol. 8, Iss. 21, pp. 34405-34422
Open Access | Times Cited: 74
Programmable prodrug micelle with size-shrinkage and charge-reversal for chemotherapy-improved IDO immunotherapy
Liangliang Dai, Xiang Li, Mengjiao Yao, et al.
Biomaterials (2020) Vol. 241, pp. 119901-119901
Closed Access | Times Cited: 68
Liangliang Dai, Xiang Li, Mengjiao Yao, et al.
Biomaterials (2020) Vol. 241, pp. 119901-119901
Closed Access | Times Cited: 68